A cyclic peptide targeted against PSD-95 blocks central sensitization and attenuates thermal hyperalgesia

This publication has 43 references indexed in Scilit:

• Disrupting specific PDZ domain‐mediated interactions for therapeutic benefit
  British Journal of Pharmacology, 2009
• Destabilization of the Postsynaptic Density by PSD-95 Serine 73 Phosphorylation Inhibits Spine Growth and Synaptic Plasticity
  Neuron, 2008
• Cell-permeable Peptide Tat-PSD-95 PDZ2 Inhibits Chronic Inflammatory Pain Behaviors in Mice
  Molecular Therapy, 2008
• Expression of AMPA Receptor Subunits at Synapses in Laminae I–III of the Rodent Spinal Dorsal Horn
  Molecular Pain, 2008
• p38 activation in uninjured primary afferent neurons and in spinal microglia contributes to the development of neuropathic pain induced by selective motor fiber injury
  Experimental Neurology, 2007
• Targeting Specific PDZ Domains of PSD-95: Structural Basis for Enhanced Affinity and Enzymatic Stability of a Cyclic Peptide
  Chemistry & Biology, 2004
• Role of postsynaptic density protein-95 in the maintenance of peripheral nerve injury-induced neuropathic pain in rats
  Neuroscience, 2003
• Spinal substance P release in vivo during the induction of long-term potentiation in dorsal horn neurons
  Pain, 2002
• The Effect of N-Methyl-D-aspartate Antagonist (Ketamine) on Single and Repeated Nociceptive Stimuli
  Anesthesia & Analgesia, 1995
• Nociceptor modulated central sensitization causes mechanical hyperalgesia in acute chemogenic and chronic neuropathic pain
  Brain, 1994